Search results
The page "Expert Review of Pharmacoeconomics" does not exist. You can create a draft and submit it for review or request that a redirect be created, but consider checking the search results below to see whether the topic is already covered.
- happened: the impact of interrupting entry of innovative drugs on disease outcomes in the United States". Expert Review of Pharmacoeconomics & Outcomes Research:...6 KB (675 words) - 08:01, 11 December 2023
- Expert Review of Pharmacoeconomics & Outcomes Research is a bimonthly peer-reviewed medical journal covering all aspects of pharmacoeconomics. It was...2 KB (116 words) - 00:56, 26 April 2023
- Types of melanoma)effectiveness vs. affordability in the age of immuno-oncology cancer drugs". Expert Review of Pharmacoeconomics & Outcomes Research. 18 (4): 351–357. doi:10...154 KB (16,071 words) - 02:37, 13 June 2024
- Group psychotherapy (category Wikipedia neutral point of view disputes from September 2023)Internet: a systematic review of applications, clinical efficacy and cost–effectiveness". Expert Review of Pharmacoeconomics & Outcomes Research. 12...28 KB (3,348 words) - 10:41, 27 December 2023
- Classification of asthma)"Quality of life in pediatric asthma patients and their parents: a meta-analysis on 20 years of research". Expert Review of Pharmacoeconomics & Outcomes...166 KB (17,945 words) - 23:59, 11 June 2024
costs and quality of life outcomes following gender affirming surgery in trans men: a review". Expert Review of Pharmacoeconomics & Outcomes Research...27 KB (3,323 words) - 04:30, 25 May 2024 - Regulation of psychotherapy)Internet: a systematic review of applications, clinical efficacy and cost–effectiveness". Expert Review of Pharmacoeconomics & Outcomes Research. 12...130 KB (14,033 words) - 03:01, 13 June 2024
Papatsoris A (October 2017). "Therapeutic outcomes of the LHRH antagonists". Expert Review of Pharmacoeconomics & Outcomes Research. 17 (5): 481–488. doi:10...23 KB (1,939 words) - 05:57, 10 June 2024
Cancer survivor (section Needs of cancer survivors)fatigue: prevalence, assessment and treatment strategies". Expert Review of Pharmacoeconomics & Outcomes Research. 11 (4): 441–6. doi:10.1586/erp.11.44...65 KB (7,570 words) - 22:40, 4 June 2024
evidence for favorable cost-effectiveness of elderly influenza vaccination". Expert Review of Pharmacoeconomics & Outcomes Research. 6 (2): 215–27. doi:10...178 KB (17,812 words) - 16:11, 23 June 2024 - cost-effectiveness of smartphone urinalysis albumin screening for people with diabetes in England". Expert Review of Pharmacoeconomics & Outcomes Research...10 KB (852 words) - 06:24, 20 April 2024
"The process of reconciliation: evaluation of guidelines for translating quality-of-life questionnaires". Expert Review of Pharmacoeconomics & Outcomes...42 KB (5,227 words) - 12:11, 5 March 2024
- Health Economists Need to be Ready to Take the Baton [Internet]. PharmacoEconomics Open 4, 557–561; 2020. Available from: https://doi.org/10.1007/s41669-020-00228-5